Kymera Therapeutics Inc. (KYMR)
NASDAQ · Healthcare
Kymera Therapeutics Inc. Cash on Hand 2019–2025
Kymera Therapeutics Inc. annual/quarterly cash on hand history from 2019 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- Kymera Therapeutics Inc. cash on hand for the quarter ending December 31, 2025 were 357.0M, a 196.88% increase year-over-year.
- Kymera Therapeutics Inc. cash on hand for 2025 were 357.0M, a 196.88% increase from 2024.
- Kymera Therapeutics Inc. cash on hand for 2024 were 120.3M, a 9.36% increase from 2023.
- Kymera Therapeutics Inc. cash on hand for 2023 were 110.0M, a 60.78% increase from 2022.
- Kymera Therapeutics Inc. cash on hand for 2022 were 68.4M.
Cash on Hand
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Kymera Therapeutics Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $357 |
| 2024 | $120 |
| 2023 | $110 |
| 2022 | $68 |
| 2021 | $48 |
| 2020 | $31 |
| 2019 | $76 |
| Kymera Therapeutics Inc. Quarterly Cash on Hand (Millions of US $) | |
|---|---|
| 2025-12-31 | $357 |
| 2024-12-31 | $120 |
| 2023-12-31 | $110 |
| 2022-12-31 | $68 |
| 2021-12-31 | $48 |
| 2020-12-31 | $31 |
| 2019-12-31 | $76 |
Kymera Therapeutics Inc. Cash on Hand — FAQ
Kymera Therapeutics Inc. (KYMR) cash on hand over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see KYMR's cash on hand history?
The chart and table above show Kymera Therapeutics Inc.'s cash on hand by year and by quarter, including the growth rate.